Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT

Van Geuns RJ, Chang CC, Chevalier B, Gori T, Barbato E, Tarantini G, Achenbach S, Dudek D, Escaned J, Abdel-Wahab M, Esposito G, Tijssen J, Morice MC, Onuma Y, Smits P (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: ELSEVIER SCIENCE INC

City/Town: NEW YORK

Pages Range: B48-B48

Conference Proceedings Title: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Event location: San Diego, CA US

DOI: 10.1016/j.jacc.2019.08.079

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Van Geuns, R.-J., Chang, C.-C., Chevalier, B., Gori, T., Barbato, E., Tarantini, G.,... Smits, P. (2019). Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (pp. B48-B48). San Diego, CA, US: NEW YORK: ELSEVIER SCIENCE INC.

MLA:

Van Geuns, Robert-Jan, et al. "Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT." Proceedings of the 31st Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Diego, CA NEW YORK: ELSEVIER SCIENCE INC, 2019. B48-B48.

BibTeX: Download